Certara, a biosimulation and drug-development technology provider, employs roughly 550 people worldwide. Recent staffing data indicate about 40 new hires and 48 departures, producing a slight net contraction while maintaining a sizable global team. The organisational mix of software, consulting, and regulatory science roles underscores Certara’s multidiscipline approach to supporting pharmaceutical and biotech clients.
Engineering is the company’s largest function with approximately 140 employees, highlighting Certara’s focus on product development and scientific computing. Marketing & Product (around 89) and Business Management (about 87) form the next-largest groups, reflecting continued investment in go-to-market strategy and corporate operations. Sales & Support counts roughly 76 specialists, while Finance & Administration totals 35. Smaller teams in Education, Legal, IT, Operations, and other categories bring the remaining headcount to just over 500, with minimal or no staffing in Real Estate roles at present.
Headcount is widely distributed. The single largest concentration is in Philadelphia with about 51 employees, followed by Raleigh-Durham, Boston, and New York, each hosting several dozen team members. International representation includes the Greater Sheffield Area in the UK and offices in Montreal, complemented by smaller U.S. hubs such as St. Louis, Seattle, and the San Francisco Bay Area. More than half of Certara’s workforce is classified under remote or other locations, illustrating a flexible approach to talent placement and a geographically diverse footprint.